Healogics Scales U.S. Advanced Wound Care Network to 600-Plus Centers, Backed by Five-Million-Wound Clinical Database

SHERIDAN, WYOMING - April 14, 2026 - Healogics, LLC, headquartered in Jacksonville, Florida, operates more than 600 hospital-based Wound Care Centers® across the United States, making it the country's largest provider of advanced wound care and hyperbaric oxygen therapy. The company has treated patients with chronic wounds for 30 years, currently serving over 300,000 patients annually and reporting nearly four million wounds healed across its managed network. With an estimated seven million Americans living with chronic, non-healing wounds, Healogics positions itself as a clinical and operational resource for hospital systems, payers, and providers seeking to reduce the long-term burden of complex wound management.

Business impact

Chronic wounds impose a substantial clinical and economic cost that extends well beyond the wound itself. Healogics reports that approximately 30 percent of untreated chronic wounds result in amputation, and that the five-year post-amputation mortality rate reaches approximately 75 percent. One in four U.S. families has a member living with a chronic wound, translating the problem from a specialty care niche into a broad population health issue with direct downstream consequences. For hospitals and health systems, these outcomes carry measurable implications for readmission rates, long-term care utilization, and performance under value-based care frameworks. The company's managed center model-placed within host hospital facilities-gives operators a structured entry point into specialized wound care without requiring proprietary infrastructure development.

Wound Science Initiative

The Healogics Wound Science Initiative is a formal research program applying clinical data from across the company's network to advance evidence-based wound care. The initiative draws on a proprietary database exceeding five million wound records, accumulated over three decades of patient treatment and supplemented by partnerships with academic and scientific institutions. Research outputs cover debridement modalities, COVID-19-related increases in amputation rates, the clinical impact of stalled wounds on patient outcomes, and wound complications arising from radiation treatment. Healogics states that patients treated within its network heal faster than those receiving generalized wound care, attributing this to protocols derived from its data infrastructure. For health systems evaluating specialty care partnerships, access to outcomes data at this scale represents a verifiable clinical differentiator.

Network and stakeholder model

Healogics operates its Wound Care Centers as hospital-based facilities staffed by specialty-trained wound care physicians capable of treating a broad range of chronic wound types. The company structures its professional engagement across four distinct segments: hospitals, independent providers, payers, and suppliers each carry dedicated partnership and referral pathways. Patient access is available without physician referral, lowering the barrier for individuals presenting with chronic wounds who may not yet be in an active care pathway. Hyperbaric oxygen therapy is integrated as a standard treatment option alongside advanced wound care protocols, broadening the clinical range of each center and expanding billable service capacity for host facilities.

Sector scale and compliance context

Advanced wound care operates at an intersection of chronic disease management, surgical follow-up care, and population health, giving it relevance across multiple care settings and payer structures. Healogics' current footprint-600-plus active centers, over 300,000 annual patients, and 30 years of operational continuity-represents the largest single-operator presence in the U.S. wound care market. The company's Jacksonville, Florida home office coordinates operations, compliance, and clinical development for the full network. Notices published on the company's website referencing third-party data incidents involving TriZetto and Pinnacle Holdings indicate that Healogics has disclosed data-related events, a compliance consideration relevant to partner organizations conducting vendor risk assessments.

Key facts:

  • Healogics operates more than 600 hospital-based Wound Care Centers® across the United States
  • The company treats over 300,000 wound care patients per year and has healed nearly 4 million wounds to date
  • An estimated 7 million Americans live with chronic, non-healing wounds
  • Approximately 30% of untreated chronic wounds lead to amputation; five-year post-amputation mortality is approximately 75%
  • The Wound Science Initiative is supported by a proprietary database of more than 5 million wound records
  • Data incident notices referencing TriZetto and Pinnacle Holdings are published on the company's website
Published by:
fairsonline_team
Company
Target market(s)